Uniranso Capsule 15 mg (Lansoprazole)

Adult dose

This drug should be administered before meals. For patients who have difficulty swallowing the medicine, open the capsule, mix the contents with a small amount (60 mL) of orange juice or tomato juice, and administer immediately. To ensure that the entire dose is taken, rinse the glass with twice or more the volume of juice and drink immediately. After opening this drug, do not chew or crush it before taking it. 1. Short-term treatment of active duodenal ulcers: Administer lansoprazole 15 mg orally once daily for 4 weeks. 2. Short-term treatment of active benign gastric ulcers: Administer lansoprazole 30 mg orally once daily for 8 weeks. 3. Eradication of Helicobacter pylori to prevent recurrence of duodenal ulcers 1) Administer lansoprazole 30 mg with clarithromycin 250 ∼ 500 mg and amoxicillin 1,000 mg twice daily (every 12 hours) for 7 days. If necessary, treatment may be continued for up to 14 days. 2) Administer lansoprazole 30 mg in combination with amoxicillin 1,000 mg 3 times daily (every 8 hours) for 14 days. 4. Maintenance therapy after treatment of duodenal ulcers: Administer lansoprazole 15 mg orally once daily. The duration of comparative clinical trials did not exceed 12 months. 5. Treatment of nonsteroidal anti-inflammatory drug-induced gastric ulcers: Administer lansoprazole 30 mg orally once daily for 8 weeks. The duration of comparative clinical trials did not exceed 8 weeks. 6. Reduction of the risk of nonsteroidal anti-inflammatory drug-induced gastric ulcers: Administer lansoprazole 15 mg orally once daily for 12 weeks. The duration of comparative clinical trials did not exceed 12 weeks. 7. Short-term treatment of symptoms associated with gastroesophageal reflux disease Administer lansoprazole 15 mg orally once daily for 8 weeks 8. Short-term treatment of erosive reflux esophagitis: Administer lansoprazole 30 mg orally once daily for 8 weeks. 9. Maintenance therapy after treatment of erosive reflux esophagitis: Administer lansoprazole 15 mg orally once daily. 10. Pathological hypersecretory conditions, including Zollinger-Ellison syndrome The dosage of lansoprazole for pathological hypersecretory conditions varies according to the individual patient. Treatment in adults is usually initiated at 60 mg once daily. The dose should be adjusted according to the patient's needs and may be continued for as long as it is clinically effective. Doses of up to 90 mg twice daily have been administered. If the daily dose exceeds 120 mg, it should be given in divided doses. Because clearance of this drug is decreased in elderly patients, dose adjustment is required. Do not exceed a daily dose of 30 mg. Since metabolism and excretion of this drug may be delayed in patients with hepatic impairment, administer with caution, including dose adjustment.

Child dose

Children and adolescents aged 12 ∼ 17 years — Short-term treatment of symptoms associated with non-erosive gastroesophageal reflux disease: 15 mg once daily for 8 weeks Children and adolescents aged 12 ∼ 17 years — Short-term treatment of erosive reflux esophagitis: 30 mg once daily for 8 weeks Children aged 1 ∼ 11 years, 30 kg or less — Short-term treatment of symptoms associated with gastroesophageal reflux disease and erosive reflux esophagitis: 15 mg once daily for 12 weeks Children aged 1 ∼ 11 years, over 30 kg — Short-term treatment of symptoms associated with gastroesophageal reflux disease and erosive reflux esophagitis: 30 mg once daily for 12 weeks

This drug should not be administered to patients who are allergic to specific ingredients or benzimidazole derivatives. Avoid use in patients with penicillin or macrolide antibiotic allergies. Especially, pregnant patients or those with genetic issues like lactose intolerance should not take this medication. Use with caution in patients with a history of drug hypersensitivity, liver function issues, the elderly, nursing mothers, and children. Severe side effects such as anaphylaxis, blood abnormalities, liver dysfunction, or serious skin reactions may occur while using this drug, so monitoring for symptoms is necessary. Long-term use may lead to nutritional deficiencies such as vitamin B12 deficiency or hypomagnesemia, thus regular testing is required. Additionally, due to the suppression of gastric acid secretion, the risk of gastrointestinal infections may slightly increase, so if symptoms like diarrhea persist, consultation with healthcare professionals is recommended. There may be interactions when used with other medications, so caution is needed particularly with antibiotics, antiviral agents, anticoagulants, immunosuppressants, etc. It is safer for pregnant or breastfeeding women to avoid this drug, and if unavoidable, they should consult a specialist before deciding. Children and the elderly may have different drug metabolism and reactions, so dose adjustment and careful observation are necessary. In case of overdose, gastric lavage or symptomatic treatment may be required, and this drug is not removed by hemodialysis. Store the medicine out of reach of children and do not transfer it to another container; avoid using dispensing devices for oral tablets. If any abnormal symptoms or suspected side effects occur during treatment, inform healthcare staff immediately.

Anaphylactic reaction, systemic rash, facial swelling, dyspnea, shock, pancytopenia, agranulocytosis, hemolytic anemia, neutropenia, thrombocytopenia, anemia, jaundice, elevated AST, elevated ALT, toxic liver dysfunction, toxic epidermal necrolysis, Stevens-Johnson syndrome, DRESS syndrome, interstitial pneumonia, fever, cough, abnormal lung sounds, interstitial nephritis, acute renal failure, membrane colitis, hematochezia, abdominal pain, diarrhea, headache, abdominal distension, allergic reaction, back pain, weakness, candidiasis, neoplasm, chills, chest pain, edema, fever, influenza symptoms, halitosis, infection, fatigue, neck stiffness, pelvic pain, angina, arrhythmia, bradycardia, tachycardia, cerebrovascular accident, cerebral infarction, hypertension, hypotension, migraine, myocardial infarction, palpitations, vasodilation, syncope, asthma, bronchitis, increased cough, epistaxis, hemoptysis, hiccups, pneumonia, upper respiratory tract infection, laryngeal tumor, pulmonary fibrosis, pharyngitis, pleural disorder, respiratory disorder, rhinitis, sinusitis, wheezing, acne, hair loss, pruritus, rash, urticaria, contact dermatitis, dry skin, nail disease, skin cancer, skin disorder, sweating, abnormal vision, amblyopia, blepharitis, cataract, conjunctivitis, dry eye, ear disease, eye disease, glaucoma, olfactory dysfunction, photophobia, retinal degeneration, taste loss, visual disturbance, deafness, ocular pain, otitis media, dysgeusia, tinnitus, visual constriction, urinary dysfunction, nephralgia, penile disease, testicular disease, urethral pain, polyuria, frequent urination, urine retention, menstrual irregularities, chest tenderness, chest expansion, gynecomastia, diabetes, hematuria, erectile dysfunction, kidney stones, abdominal pain, diarrhea, dysgeusia, abdominal bloating, nausea, vomiting, stomatitis, glossitis, thirst, heartburn, gastroesophageal reflux, loss of appetite, neutropenia, eosinophilia, leukocytosis, thrombocytopenia, rash, itching, drowsiness, dizziness, insomnia, paralysis, depressive state, elevated triglycerides, elevated uric acid, elevated total cholesterol, reduced total cholesterol, positive urine protein, positive urine glucose, fatigue, hepatotoxicity, pancreatitis, dysgeusia, aplastic anemia, thrombotic thrombocytopenic purpura, hypomagnesemia, Clostridium difficile-associated diarrhea, fracture, myositis, erythema multiforme, acute generalized pustular psoriasis, speech disorder, urinary retention, elevated AST, elevated ALT, elevated ALP, elevated LDH, elevated γ-GTP, weakness, hyponatremia, paralysis of the tongue and lips, limb paralysis

This medication must be stored in a tightly sealed container to protect it from air or moisture and maintained at a temperature between 1 to 30 degrees Celsius. Storing it this way will preserve its effectiveness and ensure safe use.

Appearance

A hard capsule with a white upper part and a yellow lower part filled with white to light brown granules

Package unit

28 capsules/bottle, 30 capsules/bottle, 90 capsules/bottle